The Role of Applied Statistics in Drug Development and Clinical Trials
Research of Scientia Naturalis · 27.12.2024 · 1 (6) · 288-297
DOI: 10.70177/scientia.v1i6.1584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research of Scientia Naturalis, online erschienen am 27.12.2024. Verfasst von Sitti Rahmah und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
The integration of applied statistics in drug development and clinical trials is essential for ensuring the efficacy and safety of new pharmaceuticals. Statistical methods play a critical role in designing studies, analyzing data, and interpreting results, thereby influencing regulatory decisions and clinical practices.
Objective
This study aims to examine the role of applied statistics in the drug development process, particularly within clinical trials. The focus is on identifying key statistical techniques and their impact on trial outcomes and decision-making. Methodology: A comprehensive review of literature was conducted, analyzing various statistical methods employed in clinical trials, including sample size determination, randomization techniques, and data analysis methods. Case studies were included to illustrate the application of these methods in real-world scenarios.
Results
Findings indicate that robust statistical methodologies significantly improve the reliability of clinical trial results. Proper sample size calculations ensure adequate power to detect treatment effects, while randomization techniques minimize bias. Additionally, advanced data analysis methods enhance the interpretation of trial outcomes, leading to more informed regulatory approvals.
Conclusion
This research highlights the indispensable role of applied statistics in drug development and clinical trials. Emphasizing the importance of sound statistical practices not only improves trial integrity but also contributes to the overall success of new drug therapies. Continued advancements in statistical methods will further enhance the efficiency and effectiveness of clinical research.
Zitieren
APA
Rahmah, S., Fawait, A. B., & Hasyim, D. M. (2024). The Role of Applied Statistics in Drug Development and Clinical Trials. Research of Scientia Naturalis, 1(6), 288-297. https://doi.org/10.70177/scientia.v1i6.1584
Vancouver
Rahmah S, Fawait AB, Hasyim DM. The Role of Applied Statistics in Drug Development and Clinical Trials. Research of Scientia Naturalis. 2024;1(6):288-297. doi:10.70177/scientia.v1i6.1584
BibTeX
@article{Rahmah2024,
author = {Rahmah, Sitti and Fawait, Aldi Bastiatul and Hasyim, Dadang Muhammad},
title = {The Role of Applied Statistics in Drug Development and Clinical Trials},
journal = {Research of Scientia Naturalis},
year = {2024},
volume = {1},
number = {6},
pages = {288--297},
doi = {10.70177/scientia.v1i6.1584}
}
EUVIMED